Peer Review History
| Original SubmissionJuly 16, 2019 |
|---|
|
PONE-D-19-20032 Decline of physical activity from childhood to adolescence: A 3-year longitudinal study PLOS ONE Dear Prof. Starc, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see below for extensive and detailed comments from two expert reviewers. While both reviewers see interest and merit in your study, they have comments and concerns about various aspects of the paper, all of which should be addressed fully in your revision. We would appreciate receiving your revised manuscript by Nov 18 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Kathryn L. Weston, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Oversell, the results of the study are relevant in determining PA levels of boys and girls in Slovenia. However, the paper requires some major modifications in terms of how the data is reported and interpreted, to ensure clarity to the reader. The discussion and conclusion should support the findings, without overstating or establishing any causal inference. Abstract Line 17: please change ‘The study’ to ‘This study’ Line 18: please change to ‘boys and girls aged 11 and 14’. Please state n = for each age. From this sentence, it is not clear if the 11 year olds and 14 year olds were the same children (i.e. you analyzed their PA at aged 11, and then followed up 3 years later by analyzing their PA levels again at aged 14). Please make this clear to the reader. Also, can you please state how long they wore the Bodymedia for (i.e. how many days), and if the measurements were taken at the same time of year (please provide month and date) Line 20-21: It is not clear about when PA was measured, and what you mean by subsample at the age 11, and final subsample at age 11 and 14. Can you please re-word to clarify this for the reader Line 21: please use abbreviation (MVPA) Line 22: please clarify what you mean by ‘longitudinally measured’ and provide n =. What ages are you referring to? Both 11 and 14 years? Or just 11 years? And how did you compare? Line 23: please add ‘a’ before representative, and delete ‘the’ before age 11 Line 24: please use abbreviation (MVPA) Line 24 – 24: compared to what? Lines 24-26: please provide p values. The results section is not clear for the reader. You have ES, the eta squared symbol, and p values. Can you please provide a concise statement about the results, and use consistent reporting values (i.e. p values, ES, t values, f ratios etc) Line 28: please use abbreviation (MVPA) Line 28-29: please use abbreviation (MVPA) Lines 30-32: The conclusions do not match the aim or findings. Can you please reword to include an appropriate conclusion based on the findings, as you do not directly measure schoolwork, participation in PE lessons, or extracurricular PA/PA outside the school environment Introduction Line 35: please delete the full stop and ‘it’, and replace with ‘and’ is one of the ….. Line 41: please add ‘the’ before adult Line 42: please insert a comma before which Line 43: please write World Health Organization in full before abbreviating Line 48: ‘suitable contents’ is not clear for the reader. Can you please define Lines 49 – 52: is there any evidence that the guidelines should differentiate between childhood and adolescence? Could you please clarify what you mean by childhood and adolescence (i.e. provide the ages in years). Is there any evidence that you can provide to support increased sedentary behavior in adolescence? Lines 52-54: can you please provide the specific ages of childhood and adolescence (see comment above), and also provide evidence to support why it is important to analyse these changes. What does the literature state in terms of the transition from childhood and adolescence? How does this impact PA in adulthood etc. Lines 54-56: I am not sure that ‘the matter is further complicated’ in relation to your study, as you are not comparing children from different countries, only Slovenia. So I would delete ‘the matter is further complicated’. You also use the word ‘different’ three times in this sentence. Could you please reword to allow the sentence to flow better for the reader Line 59: please provide evidence that the age groups you are referring to are the ‘most problematic’ Line 63 delete ‘the’ before recent Paragraph two (lines 60 – 78): I am not sure on the relevance of the paragraph to your study. You discuss advantages and limitations of questionnaires, DLW and accelerometers (none of which are utilized in your study). But you do not mention wearable technologies. And then the paragraph suddenly finishes, and moves on to discuss PA in Slovenia, which does not flow. As you are not comparing these methods (i.e. questionnaires, DLW or accelerometers) in your study I would remove this paragraph, and include pertinent and relevant information on wearable technologies and the use of the Body Media Sense wear armband to assess PA in children Line 79: please specify the ages of the school children Lines 81-86: Here you define preadolescents, and puberty. However, in the first paragraph (lines 50-51) you talk about the difference between childhood and adolescence. As you are only looking at PA in children aged 11 and 14, I do not think you can refer to ‘issues/problems’ between childhood and adolescence (in the first paragraph), as you are not actually measuring this in your study. The world health organization defines adolescence as between the ages of 10 and 19. Early adolescence (i.e. puberty) may be defined as ages 10-14. I would suggest therefore, that you temper your introduction (particularly the first paragraph), as you are not really examining differences in PA between childhood and adolescence, but looking at the change in PA during early adolescence (i.e. puberty) Line 81-82: please see comment above. Are you sure that 15-18 y is ‘preadolescent’? Or is this age group mid adolescence? My understanding is that 10-14 y is ‘preadolescent’. Lines 83-91: This information would be better suited to the methodology section. It is also not clear from these sentences exactly how you will control for biological maturity. What do you mean by discriminating factor? How will you control for this in the analyses? Please state this clearly in the methodology section only (i.e. PHV) was entered as a covariate Can you please provide a hypothesis. And also state how long you will measure PA for. You mention ‘longitudinally’. But do you just mean you will analyze their PA once when they are 11, and once again when they are 14. How long will you analyse PA for? Methods Line 96. What is ACDSi. Please define this abbreviation Line 98. What do you mean by ‘multiple location approach’. Was their random stratified sampling from each area of the country? Line 103. How were the subsample of n = 160 chosen? Was their random stratified sampling of the 385 children eligible? Line 107: please delete of before 14 Line 108-109: how did you define sufficient wear time? Line 128: delete ‘also’ before in Line 129: why was a 7 d period chosen? Due to logistical reasons (i.e. amount of kit)? Does 7 d provide a reliable and valid measure of PA in these children? Lines 132-134. What is this cut off based on? Why 5 d? and why > 90%? Line 148: To have worn the devices for 7 d should the collection not have bene the following Wednesday? Or am I missing something Lines 166 – 172. It is a little difficult to follow as a reader, who did not conduct the study, what you mean by first to second round of PA. Is this from October 2013 (i.e. aged 11), to October 2016 (i.e. aged 14)? What do you mean ‘final subsample’, and ‘initial subsample’, and ‘total sample’. Please be very clear and specific about the time (i.e. month/year), number and ages of children, sex etc that you are referring to Line 171: please insert ‘the’ before following Line 181: please state which variables, rather than just ‘multiple variables’ Line 182: provide n for ‘total sample’, provide n = for subsample, provide n = for subsample at age 11. I found it difficult to read this sentence, and to follow exactly which samples/children you are referring to. Lines 182-187 may be more useful in line 165 Line 188: please state that SPSS was used in the first sentence, prior to stating a t-test was conducted Can you please state how data is presented (e.g. mean and SD), and how effect sizes were calculated Results: Lines 198-200. Again this sentence is difficult to follow as a reader. Are you just repeating what you have mentioned in the methods section? Please be very clear and specific about the time (i.e. month/year), number and ages of children, sex etc that you are referring to. I would delete lines 198-200 Line 199: insert ‘the’ before subsample Line 201. Please define ‘groups’ Line 205: please subscript the degrees of freedom Line 208: can you please provide a citation to support his Table 1: can you please removed the borders in the middle of the table, and only include borders at the top and bottom. Can you please state what you mean by average (was this the mean). Please include the mean and SD in one column only. Please include the minimum and maximum in once column only. Is there a reason why you are reporting both min-max and mean (SD)? Please use the SI units for age (i.e. y) Line 215: when you state sig more PA. Do you mean MVPA was higher at age 11 compared to age 14? Or are you talking about total EE? Please format the parentheses appropriately and include the ES in the same parenthesis. Is this eta squared ES? Please include ES for all analyses Please be consistent with your terminology. You state on line 217 the ‘difference in MVPA’. Whereas again on line 218 you refer to ‘more active’. As you are not measuring overall PA, but looking at MVPA minutes, please use MVPA consistently, and remove any reference to ‘more physical activity’. I cannot see any reference to total EE. Is this what you mean by ‘more physically active’ – please use consistent terminology relevant to your outcome measures Line 221 – 222.: please delete this sentence. Please make the results concise and clear. You have already described the analyses conducted in the analyses section, so you do not need to repeat again how the analyses was conducted Line 222: Delete independent sample t test, and just sate what was found Line 227: p<0.5 would not be significant. Is this a typing error? Lines 227-229: can you please include the eta square value in the same parenthesis Line 232: please delete Discussion Line 237: please delete the word critical, as we cannot determine causal inference that it is indeed critical. By PA do you mean MVPA or TEE? Line 239: please delete the space between 7 and %. Can you please discuses the implications of an average of 40 min reduction in MVPA for girls aged 11 – 14, and a 10 min reduction for boys. Please discuss those who had very low MVPA (I.E. 24 or 18 min). What % of 11 and 14 year old boys and girls met the PA recommendations for Slovenia? The SD are rather large – suggesting a great deal of variance in the PA levels. Can you postulate why this is. Do you have any information on which schools these children came from, what areas they live in, their socioeconomic background etc? Lines 264-269: This sentence is very long. Can you please re-word to make it easier for the reader to follow, as numerous thoughts and points are raised in this sentence. Line 273: what do you mean by more efficient than girls of the same age in 1990? Lines 276-277. I am not sure you can make such a confident statement given you did not directly measure any changes in physical fitness Lines 278-280: Can you please reword this sentence. I do not understand what you mean by ‘the question arises as to how big a drop in PA levels from childhood does influence the physical efficiency of children when they reach adolescence’. What do you mean by efficiency? And children compared to adolescence? You only measured MVPA and total EE in 11 and 14 year olds. Lines 281-284: as you did not directly measure PA and PE lessons, or support from friends etc, can you please reword/temper these sentences and relate directly to your findings. Overall, the discussion needs some work in terms of the flow of sentences, and the tempering/relevance of the findings (see comments above on reporting total EE, discussing if differences are meaningful, reporting % of children that met PA guidelines etc). You cannot make any causal inference for some of the points you make (with regard to PE lesson, maturity etc), as you only looked at 7 d of MVPA at age 11 and age 14. Please ensure the discussion only directly relates to your findings. And any postulations are interpreted with caution. Line 294-295. Please reword. It is not clear that you are discussing the wear time of the SWA in the present study compared to previous research. Lines 300-301. Can you make this sentence more concise. You mention consistent measurement equipment and criteria separately, objective EE assessment. Are you simply referring to using the SWA with the PHV. Please use specific and consistent terminology, and do not overstate the measurements. Please provide the reference for the SWA being valid and reliable for MVPA and EE use over 7 d in children. With regards to the limitations, please also acknowledge only analyzing the PA for one week. You do not mention any data collection in terms of PE lesson, outside school PA or exercise, illness etc which may have been important for interpreting the findings Line 321. Please insert pre-adolescents. Please replace similarly with similar Line 323-324. You cannot determine causal inference from puberty (i..e PHV) and MVPA. It was only inserted as the covariate. It may not have been the reason why girls decreased their MVPA. I would suggest that future research needs to explore (quantitatively and qualitatively) the reasons why girls are decreasing their MVPA in Slovenia. Lines 326 – 330. Can you please temper and/or remove these sentences. As they are not measured or related to the outcomes in your study. Please ensure the conclusion is relevant to the discussion and results Reviewer #2: I was asked to read an interesting manuscript titled “Decline of physical activity from childhood to adolescence: A 3-year longitudinal study” by Dr. Sember et al. The study investigated the changes in physical activity during 3y follow-up period in adolescents and showed interestingly that MVPA declined in girls but not in boys. General comments Although the introduction describes important areas related to this study, it does not adequately describe the available evidence on the decline of physical activity from previous studies. The Authors also bring some ideas that maturation is important in study of changes in physical activity, but do not explain why and what is the evidence. Please revise the introduction to better cover previous evidence and to explain what is needed and what gaps this study fills. The Authors used a physical activity monitor that was used continuously trough 24 hours. Why the Authors only study MVPA and not sedentary behaviour and sleep. That would strengthen the paper significantly. Specific comments L79-81. The children in Slovenia are one of the most active paediatric populations. Please define how this was measured. L95-115. A lot of children dropped off the study How representative this sample was regarding available characteristics such as socioeconomic status, body composition and size (e.g. BMI percentile/sd-score, body fat percentage). Please define these information here and not just in the results. L127-128. Can the Authors define how SWA was validated. Was it validated against doubly labelled water? What was the agreement between methods. Please expand this information. L134-135. Please comment the epoch length. Can the Authors show that 60 s epoch length can capture physical activity level reliably. Some studies have shown that 60 s epoch is not able to capture true levels of moderate and vigorous physical activity (1). L158-163. The Authors need to put more emphasis in the validity of their physical activity data. For example, it is important to describe whether adult derived MET definition (3.5 mL/kg/min) was used or was more appropriate definition used. There are strong data suggesting that adult derived METs are not suitable to used in children (2). Furthermore, METs can produce a significant bias in physical activity assessment (3) and fixed MET thresholds for moderate and vigorous physical activity underestimate true prevalence of physical activity in overweigh and low fit individuals (4). Therefore, I suggest that the Authors carefully describe the procedure used in the study, consider their effect on the results, and highlight these in the limitations. It seems that the Authors have data on 20 metre shuttle run test. Although it is not the most valid method to assess cardiorespiratory fitness especially during puberty, it could be used to assess maximal endurance capacity in adolescents. Can the Authors use those results to individually calibrate physical activity intensity? This would be important next step in physical activity research. Some of these limitations are partly covered in the limitations section, but these needs to be expanded. L163-165. Please describe which formula was used to calculate maturity offset? Mirwald or Moore? Please also describe the whole formula and its validity in this age group. L182-183. Please describe Mirwald method earlier. Please also note that age at peak height velocity is not equal to onset of puberty which is mostly assessed as transition from stage 1 to stage 2 in stages described by Tanner. Please revise the terminology accordingly. L192-194. How maturity was used in the model as covariate? It was a bit unclear to me was it only baseline maturity or change in maturity. It is important also to control changes in maturity because at any age children and adolescents mature at different rates. L193-195. It not clear here whether time x sex interaction were studied or how data was in fact analysed. A figure of results could make it clearer and show the trend of physical activity level and interactions in boys and girls. L216. Please describe how ES was defined. L126-232. Does this mean that the results did not change when maturity was adjusted for? It is still a bit unclear whether only baseline maturity was used as a covariate. It would be important to know whether larger changes in maturity (i.e. faster rate of maturation) are related to for example larger decline in physical activity especially in girls. Furthermore, be also aware when interpreting the data using METs that changes in body composition during pubertal development are different in males and females with increased body adiposity in females and decreased adiposity in males. These changes may have an influence on MET-based estimates of physical activity as MET itself is adiposity confounded metric. L237-239. Although merely speculative, is it possible that the decline of physical activity in girls is just because of increasing adiposity as suggested by Kujala et al. (4). Thus, are the same fixed intensity thresholds valid in assessment of physical activity intensity especially during youth when body size and composition as well as physical fitness change remarkably. Please consider these issues at least in limitations. L248-258. As the Authors state school is probably important factor influencing physical activity and sedentary time in youth. I suggest that the Authors consider also biological explanations explained for example in the article by Eisenmann and Wickel (5). L262-264. The Authors state that there were no differences in physical activity at the age of 11 and 14 after adjustment for maturity. I was wondering that wasn’t this the case also without the adjustment. Please clarify. Please also consider my other comments on maturity. L271-274. Please describe what the Authors mean by physical efficiency. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Eero Haapala [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Decline of physical activity in early adolescence: A 3-year cohort study PONE-D-19-20032R1 Dear Dr. Starc, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Kathryn L. Weston, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Please ensure that the minor typographical requests from Reviewer 1 are addressed in the final manuscript submission. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have done an excellent job in responding to the comments, and the manuscript has been greatly improved. I just have a few minor specific comments below Abstract Lines 28, 30, 31, 33: please provide p values Methods Line 113 please change N = to n = to be consistent throughout the paper Results: Line 263: here you report age as 12.01 ± 1.0. Prior to this you report your mean and SD with no space (i.e. 12.01±1.0). Please check the manuscript for consistency with spaces Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-19-20032R1 Decline of physical activity in early adolescence: A 3-year cohort study Dear Dr. Starc: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kathryn L. Weston Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .